Improved Differential Diagnosis of Alzheimer’s Disease by Integrating ELISA and Mass Spectrometry-Based Cerebrospinal Fluid Biomarkers

Alzheimer's disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Aβ 1–42 , total-tau, phosphorylated-tau, NFL, neurogranin, and YKL-40

(2018) Harald Hampel et al.   Alzheimers & Dementia

Alzheimer's disease in the omics era

(2018) Giulia M. Sancesario et al.   CLINICAL BIOCHEMISTRY

Vascular Risk Factors and Lesions of Vascular Nature in Magnetic Resonance as Predictors of Progression to Dementia in Patients with Mild Cognitive Impairment

(2018) Raul Romero-Sevilla et al.   Current Alzheimer Research

Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease

(2018) Flora H. Duits et al.   Alzheimers Research & Therapy

Identification of SPARC-like 1 Protein as Part of a Biomarker Panel for Alzheimer's Disease in Cerebrospinal Fluid

(2018) Baharak Vafadar-Isfahani et al.   JOURNAL OF ALZHEIMERS DISEASE

Are Blood-Based Protein Biomarkers for Alzheimer's Disease also Involved in Other Brain Disorders? A Systematic Review

(2018) Justin Tao Wen Chiam et al.   JOURNAL OF ALZHEIMERS DISEASE

Integration of magnetic resonance imaging and protein and metabolite CSF measurements to enable early diagnosis of secondary progressive multiple sclerosis

(2018) Stephanie Herman et al.   Theranostics

Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer’s Disease

(2017) Per Johansson et al.   JOURNAL OF ALZHEIMERS DISEASE

Apolipoprotein A1 in Cerebrospinal Fluid and Plasma and Progression to Alzheimer’s Disease in Non-Demented Elderly

(2017) Rosalinde E.R. Slot et al.   JOURNAL OF ALZHEIMERS DISEASE

Differential diagnosis of Alzheimer’s disease using spectrochemical analysis of blood

(2017) Maria Paraskevaidi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A Parallel Reaction Monitoring Mass Spectrometric Method for Analysis of Potential CSF Biomarkers for Alzheimer's Disease

(2017) Gunnar Brinkmalm et al.   Proteomics Clinical Applications

mixOmics: An R package for ‘omics feature selection and multiple data integration

(2017) Florian Rohart et al.   PLoS Computational Biology

Cognitive function in very old men does not correlate to biomarkers of Alzheimer’s disease

(2017) V. Velickaite et al.   BMC Geriatrics

Reduced Levels of Amyloid-β-Binding Proteins in Cerebrospinal Fluid from Alzheimer's Disease Patients

(2017) Sara F. Hansson et al.   JOURNAL OF ALZHEIMERS DISEASE

Cystatin C in aging and in Alzheimer’s disease

(2016) Paul M. Mathews et al.   AGEING RESEARCH REVIEWS

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease

(2016) Niklas Mattsson et al.   EMBO Molecular Medicine

OpenMS: a flexible open-source software platform for mass spectrometry data analysis

(2016) Hannes L Röst et al.   NATURE METHODS

Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease

(2015) Kaj Blennow et al.   Alzheimers & Dementia

The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer’s but Not Parkinson’s Disease or Dementia with Lewy Bodies

(2015) Malin Wennström et al.   PLoS One

Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer’s disease in a memory clinic cohort

(2015) Maartje I. Kester et al.   Alzheimers Research & Therapy

Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer’s disease

(2015) Konstantin Hellwig et al.   Alzheimers Research & Therapy

An Integrated Workflow for Multiplex CSF Proteomics and Peptidomics—Identification of Candidate Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease

(2014) Mikko Hölttä et al.   JOURNAL OF PROTEOME RESEARCH

Plasma protein profiling of Mild Cognitive Impairment and Alzheimer’s disease using iTRAQ quantitative proteomics

(2014) Fei Song et al.   Proteome Science

Plasma levels of lipocalin 2 and chitinase 3-like 1 protein in patients with amnestic mild cognitive impairment and Alzheimer's disease

(2013) Kyunghun Kang et al.   Alzheimers & Dementia

Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010

(2012) Thomas G. Beach et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Activity-dependent neuroprotector homeobox protein: A candidate protein identified in serum as diagnostic biomarker for Alzheimer's disease

(2012) Ming-Hui Yang et al.   Journal of Proteomics

Apolipoprotein A-I: Insights from redox proteomics for its role in neurodegeneration

(2012) Jeriel T. R. Keeney et al.   Proteomics Clinical Applications

Plasma level of chitinase 3-like 1 protein increases in patients with early Alzheimer’s disease

(2011) Jihye Choi et al.   JOURNAL OF NEUROLOGY

Peptide Fingerprinting of Alzheimer's Disease in Cerebrospinal Fluid: Identification and Prospective Evaluation of New Synaptic Biomarkers

(2011) Holger Jahn et al.   PLoS One

False Discovery Rates of Protein Identifications: A Strike against the Two-Peptide Rule

(2009) Nitin Gupta et al.   JOURNAL OF PROTEOME RESEARCH

A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking

(2009) C. E. Teunissen et al.   NEUROLOGY

P3-232: SNPs in SOAT1, TFAM, and CNDP1 are associated with cerebrospinal fluid amyloid-beta levels

(2008) John S.K. Kauwe et al.   Alzheimers & Dementia